ImanoH, KatoR, TanikawaS, et al.Factor Xa inhibition by rivaroxaban attenuates cardiac remodeling due to intermittent hypoxia. J Pharmacol Sci2018;137(3):274–282; doi: 10.1016/j.jphs.2018.07.002
4.
OteroL, HidalgoP, GonzálezR, et al.Association of cardiovascular disease and sleep apnea at different altitudes. High Alt Med Biol2016;17(4):336–341; doi: 10.1089/ham.2016.0027
5.
Van PatotMCT, HillAE, DingmannC, et al.Risk of impaired coagulation in warfarin patients ascending to altitude (>2400 m). High Alt Med Biol2006;7(1):39–46; doi: 10.1089/ham.2006.7.39
6.
ZhangXJ, MuHF, ZhongY, et al.Effect of high altitude environment on pharmacokinetic and pharmacodynamic of warfarin in rats. Curr Drug Metab2024;25(1):54–62; doi: 10.2174/0113892002277930240201101256
